<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00927303</url>
  </required_header>
  <id_info>
    <org_study_id>09-086-0609</org_study_id>
    <nct_id>NCT00927303</nct_id>
  </id_info>
  <brief_title>The Spectralis-Cirrus Study</brief_title>
  <official_title>Comparison of Quality and Reproducibility of Retinal Thickness Measurements in Two Spectral Domain OCT- Machines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retinal thickness measurement is one of the most important examinations in the follow up of
      exudative age-related macular degeneration. Prior studies have shown that there are a series
      of algorithm line failures in OCT examinations. This study is conducted to compare the
      quality of the examinations of to different spectral domain OCT machines concerning the
      positioning of algorithm lines. Furthermore the reproducibility of the examinations id
      tested, both machines provide different techniques to guarantee that in repeated examinations
      the same location is examined.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of examinations with correctly set threshold algorithm lines</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences of mean retinal thickness in the central region</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences of retinal volume</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance acuity</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Classification of the lesion</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Exudative Age Related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Intervention 1 Sequence of observers: observer1, observer 2, observer 1, observer 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <description>intervention 1 sequence of observers: observer 2, observer 1, observer 2, observer 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 3</arm_group_label>
    <description>intervention 2 sequence of observers: 1,2,1,2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 4</arm_group_label>
    <description>intervention 2 sequence of observers: 2,1,2,1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 5</arm_group_label>
    <description>intervention 1 sequence of observers 1,1,2,2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 6</arm_group_label>
    <description>intervention 1 sequence of observers 2,2,1,1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 7</arm_group_label>
    <description>intervention 2 sequence of observers: 1,1,2,2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 8</arm_group_label>
    <description>intervention 2 sequence of observers: 2,2,1,1</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cirrus-Spectralis</intervention_name>
    <description>512x128 c√∫be program of Cirrus OCT first retinal volume 121 line of Spectralis OCT thereafter</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_label>group 5</arm_group_label>
    <arm_group_label>group 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectralis-Cirrus</intervention_name>
    <description>retinal volume program 121 lines Spectralis OCT first 512x128 program Cirrus OCT thereafter</description>
    <arm_group_label>group 3</arm_group_label>
    <arm_group_label>group 4</arm_group_label>
    <arm_group_label>group 7</arm_group_label>
    <arm_group_label>group 8</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      male or femal persons age over 50 years with exudative age-related macular degeneration
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        male or female persons aged more than 50 years with exudative age related macular
        degeneration
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Exudative age related macular degeneration

        Exclusion Criteria:

          -  Macular pathologies other than age related macular degeneration (diabetic maculopathy,
             macular pucker, macular hole,

          -  Visualization of the macula not possible (dens cataract, vitreous haemorrhage)

          -  Not consented patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne Binder, MD, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery</name>
      <address>
        <city>Vienna</city>
        <zip>1030</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2009</study_first_submitted>
  <study_first_submitted_qc>June 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2009</study_first_posted>
  <last_update_submitted>June 8, 2010</last_update_submitted>
  <last_update_submitted_qc>June 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Ilse Krebs, MD</name_title>
    <organization>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</organization>
  </responsible_party>
  <keyword>retinal thickness</keyword>
  <keyword>threshold algorithm</keyword>
  <keyword>optical coherence tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Wet Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

